Direct To Consumer Pharmaceutical Advertising Summary

431 Words1 Page

In his article “Pharmaceutical Ads: Good or Bad for Consumers?” Larry Woodard addresses the problem of direct-to-consumer pharmaceutical advertising. In particular, the author, in a very objective way, examines different perspectives on the direct-to-consumer pharmaceutical advertising. He does not criticize the direct-to-consumer pharmaceutical advertisement in particular, but rather focuses on the problem of the pharmaceutical advertisement as a whole. Moreover, Woodard expresses a concern regarding pharmaceutical companies that “receive taxpayer subsidies” and at the same time put their own profit above their ethical obligations to the society. As for my opinion on the direct-to-consumer pharmaceutical advertisement, though I can agree with some of the points offered by the proponents of the topic; I believe pharmaceutical companies should have limited rights when advertising their products. The major issue with the direct-to-consumer pharmaceutical advertisement is premature advertisement of new drugs: Pharmaceutical companies rush into selling and advertising products …show more content…

Proponents of the topic claim that “ads inform consumers about important treatable health conditions”, but in reality the most these ads can do is raise awareness. The pharmaceutical advertisement does not provide any valuable information about health conditions; it is not a documentary or an educational movie. However, many individuals consider themselves competent enough to self-diagnose based on the pharmaceutical advertisement, thus making the job of the medical specialists harder than it already is. This new attitude of knowing better than trained professionals changes the whole dynamic of the doctor-patient relationship and undermines the medical personal’s

Open Document